Michael R. Liebling

914 total citations
21 papers, 640 citations indexed

About

Michael R. Liebling is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael R. Liebling has authored 21 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 9 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael R. Liebling's work include Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and T-cell and B-cell Immunology (4 papers). Michael R. Liebling is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and T-cell and B-cell Immunology (4 papers). Michael R. Liebling collaborates with scholars based in United States. Michael R. Liebling's co-authors include James S. Louie, Dinesh Khanna, Eugene V. Barnett, Jin Tian, M. Nishio, Bruce C. Richardson, Jerry L. Hudson, A. R. Rodriguez, Leonard H. Sigal and N T Jou and has published in prestigious journals such as Annals of Internal Medicine, Annals of the New York Academy of Sciences and Journal of Allergy and Clinical Immunology.

In The Last Decade

Michael R. Liebling

21 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Liebling United States	12	301	177	99	96	95	21	640
R. Saario Finland	15	594 2.0×	320 1.8×	105 1.1×	117 1.2×	56 0.6×	25	1.1k
Ajax Mercês Atta Brazil	19	311 1.0×	277 1.6×	59 0.6×	256 2.7×	52 0.5×	58	975
Carolyn C. Huntley United States	17	91 0.3×	208 1.2×	77 0.8×	176 1.8×	43 0.5×	34	774
M. Boy United States	15	401 1.3×	146 0.8×	129 1.3×	80 0.8×	25 0.3×	25	888
Bruce C. Gilliland United States	10	110 0.4×	185 1.0×	63 0.6×	140 1.5×	124 1.3×	20	742
Curt P. Samlaska United States	14	107 0.4×	92 0.5×	69 0.7×	151 1.6×	26 0.3×	31	786
Elaine J. Clutterbuck United Kingdom	12	145 0.5×	270 1.5×	47 0.5×	120 1.3×	41 0.4×	17	840
Ineke M. van der Heijden Netherlands	8	202 0.7×	218 1.2×	87 0.9×	128 1.3×	29 0.3×	11	631
Peter van Swieten Netherlands	19	116 0.4×	247 1.4×	213 2.2×	172 1.8×	152 1.6×	30	1.3k
R Merilahti-Palo Finland	14	515 1.7×	238 1.3×	104 1.1×	96 1.0×	35 0.4×	19	954

Countries citing papers authored by Michael R. Liebling

Since Specialization

Citations

This map shows the geographic impact of Michael R. Liebling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Liebling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Liebling more than expected).

Fields of papers citing papers by Michael R. Liebling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Liebling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Liebling. The network helps show where Michael R. Liebling may publish in the future.

Co-authorship network of co-authors of Michael R. Liebling

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Liebling. A scholar is included among the top collaborators of Michael R. Liebling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Liebling. Michael R. Liebling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liebling, Michael R., et al.. (2003). Blockade of Plasmid Replication Mediated by Peptide Nucleic Acids. Molecular Biotechnology. 25(3). 229–240. 2 indexed citations

Furie, Richard, J M Cash, MaryAnne Cronin, et al.. (2001). Treatment of systemic lupus erythematosus with LJP 394.. PubMed. 28(2). 257–65. 81 indexed citations

Louie, James S. & Michael R. Liebling. (1998). THE POLYMERASE CHAIN REACTION IN INFECTIOUS AND POST-INFECTIOUS ARTHRITIS. Rheumatic Disease Clinics of North America. 24(2). 227–236. 18 indexed citations

Jou, N T, Robert Yoshimori, Gregory R. Mason, James S. Louie, & Michael R. Liebling. (1997). Single-tube, nested, reverse transcriptase PCR for detection of viable Mycobacterium tuberculosis. Journal of Clinical Microbiology. 35(5). 1161–1165. 53 indexed citations

Liebling, Michael R., et al.. (1994). Identification of neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction. Arthritis & Rheumatism. 37(5). 702–709. 55 indexed citations

Liebling, Michael R., M. Nishio, A. R. Rodriguez, et al.. (1993). The polymerase chain reaction for the detection of borrelia burgdorferi in human body fluids. Arthritis & Rheumatism. 36(5). 665–675. 70 indexed citations

Richardson, Bruce C., Michael R. Liebling, & Jerry L. Hudson. (1990). CD4+ cells treated with DNA methylation inhibitors induce autologous B cell differentiation. Clinical Immunology and Immunopathology. 55(3). 368–381. 52 indexed citations

Liebling, Michael R., et al.. (1988). Specific suppression of anti-DNA productionin vitro. Journal of Clinical Immunology. 8(5). 362–371. 2 indexed citations

Louie, James S., et al.. (1988). Anti‐Fab Antibodies in Lyme Disease. Annals of the New York Academy of Sciences. 539(1). 393–397. 2 indexed citations

10.

Liebling, Michael R., et al.. (1985). Spontaneous in vitro production of anti‐DNA and anti‐RNA by systemic lupus erythematosus and normal peripheral blood mononuclear cells. Arthritis & Rheumatism. 28(4). 431–440. 9 indexed citations

11.

Weisbart, Richard H., et al.. (1983). Specificity of anti-nucleoside antibodies in systemic lupus erythematosus. Clinical Immunology and Immunopathology. 27(3). 403–411. 26 indexed citations

12.

Ashman, Robert F., et al.. (1982). Panhypogammaglobulinemia in systemic lupus erythematosus: in vitro demonstration of multiple cellular defects. Journal of Allergy and Clinical Immunology. 70(6). 465–473. 19 indexed citations

13.

Liebling, Michael R., et al.. (1982). Monthly pulses of methylprednisolone in SLE nephritis.. PubMed. 9(4). 543–8. 43 indexed citations

14.

Liebling, Michael R. & Richard H. Gold. (1981). Erosions of the temporomandibular joint in systemic lupus erythematosus. Arthritis & Rheumatism. 24(7). 948–950. 10 indexed citations

15.

Liebling, Michael R., et al.. (1981). Pulse Methylprednisolone in Rheumatoid Arthritis. Annals of Internal Medicine. 94(1). 21–26. 83 indexed citations

16.

Liebling, Michael R., et al.. (1980). A double-blind crossover trial of methylprednisolone pulse therapy in rheumatoid arthritis. Arthritis & Rheumatism. 23(6). 2 indexed citations

17.

Barnett, Eugene V., et al.. (1978). Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.. PubMed. 5(3). 275–87. 19 indexed citations

18.

Liebling, Michael R., Carole A. Dorsch, & Eugene V. Barnett. (1977). Substrate competition in systemic lupus erythematosus: Clinical relevance. Clinical Immunology and Immunopathology. 8(2). 345–352. 3 indexed citations

19.

Liebling, Michael R. & Eugene V. Barnett. (1977). Substrate competition between DNase I and anti-DNA antibody. Clinical Immunology and Immunopathology. 8(1). 80–89. 10 indexed citations

20.

Liebling, Michael R., Roy D. Altman, & Thomas G. Benedek. (1975). A double blind, multiclinic trial of sulindac (MG 213) in the treatment of ankylosing spondylitis. 18(4). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact